Positron Emission Tomography study of changes in [11C]AZ14132516 uptake following administration of AZD7798 to healthy participants and patients with Crohn’s disease

Trial Identifier:	D9690C00004
Sponsor:	AstraZeneca
NCTID::	NCT06053424
Start Date:	September 2023
Primary Completion Date:	August 2024
Study Completion Date:	August 2024

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
SE	Stockholm, SE, 14186

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.